Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
AV8 Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
AV8 Ventures

AV8 Ventures

Operating

AV8 Ventures: A Palo Alto-based venture capital firm, investing in visionary startups in health, mobility, and enterprise tech.

Location
Palo Alto, CA, US
Founded
2018
Firm
Compare
Portfolio
Employees
Website

AV8 Ventures is a Palo Alto-based venture capital firm focusing on early-stage startups in healthcare, enterprise technology, financial services, and deep-tech sectors. The firm typically invests in seed and Series A rounds, with a commitment to long-term partnerships and category-defining companies. AV8 Ventures manages a $360 million fund and aims to empower visionary entrepreneurs.

Notable portfolio companies include Alpha Medical, Delfi Diagnostics, and Clever Care Health Plan. The firm's investment philosophy emphasizes backing bold founders and providing hands-on support. AV8 Ventures leverages its team's deep technical, entrepreneurial, and venture experience to help startups succeed, offering a global network and decades of industry expertise to its portfolio companies.

AV8 Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments30
Current Portfolio Count18
Total Portfolio Exits0

Top Investment Stages

Seed9 (31.0%)
Series A8 (27.6%)
Series B8 (27.6%)
Series Unknown3 (10.3%)
Pre-Seed1 (3.4%)

Stage Mix

Seed 31%Series A 28%Series B 28%Series Unknown 10%Pre-Seed 3%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Cerby logo

Cerby

One Model logo

One Model

Embrace logo

Embrace

Hydrolix logo

Hydrolix

Axuall logo

Axuall

Clever Care Health Plan logo

Clever Care Health Plan

Shennon Biotechnologies logo

Shennon Biotechnologies

CuraFi logo

CuraFi

Glow logo

Glow

Eclypsium logo

Eclypsium

Think Bioscience logo

Think Bioscience

Delfi Diagnostics logo

Delfi Diagnostics

Covertree logo

Covertree

SimBioSys logo

SimBioSys

Alpha Medical logo

Alpha Medical

Measured Analytics and Insurance logo

Measured Analytics and Insurance

Locomation logo

Locomation

Brave Care logo

Brave Care

PlanetiQ logo

PlanetiQ

AV8 Ventures - Similar Investment Firms

Avestria logo

Avestria

avestria.vc

Pacific 8 Ventures logo

Pacific 8 Ventures

pac8.com

808 Ventures logo

808 Ventures

808ventures.vc

8VC logo

8VC

8vc.com

Avalon Ventures logo

Avalon Ventures

Acvc Partners logo

Acvc Partners

acvc.partners

Avalon BioVentures logo

Avalon BioVentures

408 Ventures logo

408 Ventures

August Capital logo

August Capital

augustcap.com

Level Eight Ventures logo

Level Eight Ventures

level8.vc

AVG Ventures logo

AVG Ventures

Advance Venture Partners logo

Advance Venture Partners

avp.vc

Partner Ventures logo

Partner Ventures

partnervc.com

AvanTech Ventures logo

AvanTech Ventures

avantechvc.com

AI8 Ventures logo

AI8 Ventures

AV8 Ventures - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 541000Professional, Scientific, and Technical Services
  • 523910Miscellaneous Intermediation
SIC
  • 6000Depository Institutions
  • 7300Business Services
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end